Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A06 DRUGS FOR CONSTIPATION
A06A DRUGS FOR CONSTIPATION
A06AX Other drugs for constipation
A06AX08 Tenapanor
D11653 Tenapanor hydrochloride (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Anti-constipation Agents
Tenapanor
D11653 Tenapanor hydrochloride (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D11653 Tenapanor hydrochloride (JAN/USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG03072 Tenapanor
D11653 Tenapanor hydrochloride
DG02925 CYP3A5 substrate
DG03072 Tenapanor
D11653 Tenapanor hydrochloride
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC9
SLC9A3 (NHE3)
D11653 Tenapanor hydrochloride (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11653
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11653
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11653
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11653
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG03072 Tenapanor
DG02925 CYP3A5 substrate
DG03072 Tenapanor